Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Anorexia NervosaOsteopeniaOsteoporosisEating Disorders
Interventions
DRUG

Recombinant Human Growth Hormone

Dosage increased in steps for first four weeks. Self injection qd x 12 weeks

DRUG

Placebo for Recombinant Human Growth Hormone

Administered as Arm 1, rHGH active Injection qd x 12 weeks Dosage increase over four weeks

Trial Locations (1)

02114

Massachusettes General Hospital, Boston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Massachusetts General Hospital

OTHER